In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (289)
Article
GLP-1s drive historic shift in traditional drug trend
September 26, 2025
GLP-1 medications drive unprecedented growth in traditional drug spending, surpassing specialty drug trends for the first time.
Article
Improving cancer outcomes through early detection
September 23, 2025
Cancer rates are rising, yet early detection remains underused — despite its power to improve outcomes and reduce emotional strain.
Article
Evernorth Specialty Services patient spotlight: Kenya’s story of resilience and support
September 08, 2025
Meet Kenya, an Accredo patient who is living with multiple sclerosis (MS). Watch the video to learn more about her journey of managing her condition with the support of Accredo Specialty Pharmacy.
Article
Guiding employees to care before they know they need it
September 05, 2025
Proactive benefits navigation, personalized for every health journey.
Article
Leveraging data, insights, and clinical expertise to support gene and cell therapy treatment
August 28, 2025
Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.
Article
Addressing the growing impact of gene therapies on employer plans
August 18, 2025
As the gene therapy market evolves, it’s more important than ever for employers to put the right gene therapy management program in place.
